The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging.

Journal: La Radiologia medica
Published Date: May 7, 2025

Abstract

PURPOSE: Artificial intelligence (AI) has been proposed to assist radiologists in reporting multiparametric magnetic resonance imaging (mpMRI) of the prostate. We evaluate the diagnostic performance of radiologists with different levels of experience when reporting mpMRI with the support of available AI-based software (Quantib Prostate).

Authors

  • Tommaso Russo
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Leonardo Quarta
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy. quarta.leonardo@hsr.it.
  • Francesco Pellegrino
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Michele Cosenza
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Enrico Camisassa
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Salvatore Lavalle
    Department of Medicine and Surgery, University of Enna Kore, Enna, Italy.
  • Giovanni Apostolo
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Paolo Zaurito
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Simone Scuderi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Barletta
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Clara Marzorati
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Armando Stabile
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco De Cobelli
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Giorgio Brembilla
    Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Giorgio Gandaglia
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Alberto Briganti
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals